Insurance Delays in Initiation of Tumor Necrosis Factor Inhibitors in Children With Juvenile Idiopathic Arthritis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35446398.
- Also identified by DOI 10.1001/jamanetworkopen.2022.8330 and PMC identifier 9024383.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study compares the delays in tumor necrosis factor inhibitor (TNFi) initiation because of insurance among children enrolled in public and private insurance plans.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Juvenile
- Insurance